A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders.

Sci Rep · 2018 · PMC5826917 · PMID 29483571

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

showed a trendp < 0.01actually significant

Further, the treatment group also showed a trend to a reduction in fed plasma insulin that was statistically significant on day 14 ( p < 0.01) compared to HFD control (Fig. 4B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.